ModuVision Technologies Competitors

Recognized as the #1 CX provider for disruptors and innovators across financial services, healthcare, and e-commerce, Ubiquity was founded on the belief that our clients and their customers deserve better. Headquartered in New York City with delivery locations in Europe, Asia, and the Americas, Ubiquity provides multilingual, end-to-end solutions for customer experience management, back-office operations, and business transformation.

InvenSense, a TDK Group company, is a world-leading provider of sensor solutions, including MEMS and magnetic sensors for consumer, industrial, and automotive applications. InvenSense MEMS sensors are known to be best-in-class for reasons that include high performance and reliability, high-volume manufacturing capacity and supply stability, ongoing hardware and software innovation, and ultra-low power consumption. They can be found in Mobile, Wearable, Smart Home, Industrial, Automotive, IoT, and Robotics products, among others. Founded in 2003, InvenSense has a 20+ year history of patented sensor technology across Motion, Sound, and Ultrasonic solutions, including the invention of the 6-axis IMU. InvenSense is dedicated to enabling partner success and enhancing lives through sustainable sensor innovation. In May of 2017, InvenSense became part of the MEMS Sensors Business Group of TDK Corporation, based in Tokyo, Japan. InvenSense is headquartered in San Jose, California and has offices in Boston, China, Taiwan, Korea, Japan, France, Canada, Slovakia, and Italy.

Founded in 2002 by Dr. Fred Moll, Hansen Medical pioneered the field of flexible robotic technology. Hansen manufactured two robotic systems, the Magellan Robotic System and the Sensei Robotic System. The Magellan was built for multi-specialty, peripheral vascular robotics procedures and the Sensei for interventional electrophysiology procedures. In conjunction with the Sensei Robotic System, Hansen created the Artisan Extend Control Catheter, a robotically steerable sheath designed to enable catheter stability, reachability and contact force sensing when navigating third-party catheters in electrophysiology procedures. In 2016, Auris Health acquired Hansen Medical, bringing a wealth of robotic technology and patents into the Auris portfolio. Following the Hansen integration, in March 2018, Auris Health launched the Monarch™ Platform, the first FDA-cleared robotic platform for diagnostic and therapeutic bronchoscopic procedures. The Monarch Platform is designed to allow physicians to diagnose small, hard-to-reach peripheral lung nodules with greater precision than ever before. PN: S07